News BenevolentAI to power small molecule drug discovery Deal with MRCT will look for potential new drug targets and candidates.
News Google AI detects breast cancer better than pathologists Algorithm achieves a sensitivity rate of 92%.
Views & Analysis Digital Health Round-up - Siemens and Biogen take on MS imag... A round-up of this week's digital healthcare news. Marco Ricci reports.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
